Navigation Links
Texas Eye Institute Named Official Houston Rockets Eye Care Team
Date:11/11/2008

Texas Eye Institute has been named the Official Eye Care Team of the Houston Rockets. The NBA franchise selected the eye care physician group to provide primary eye care for the team and organization.

HOUSTON, Nov. 11 /PRNewswire/ -- Texas Eye Institute and the Houston Rockets are pleased to announce that Texas Eye Institute has been named the Official Eye Care Team for the Houston Rockets.

As the official eye care partner of the Houston Rockets, Texas Eye Institute offers the team, staff and fans comprehensive eye care services including General Ophthalmology, Retina Specialist, Corneal and Pediatrics, as well as the latest in LASIK services.

Recognized as one of the Gulf Coast's premier eye care physician groups, the Texas Eye Institute provides medical expertise with a wide range of eye care services and specialties, including eye exams, cataracts, glaucoma, corneal transplants, pediatrics, laser vision correction, premium intraocular lenses and retina-vitreous care. Dedicated to providing unparalleled eye care in the Houston area since 1961, Texas Eye Institute now offers four convenient locations in Houston, Angleton and Sugar Land.

"We are proud to have a partnership with Texas Eye Institute and have named them our Official Eye Care Team," said David Fletcher, Corporate Development Manager for the Rockets. "The fact that Texas Eye Institute is able to offer the Rockets Organization and their fans such a broad spectrum of vision care and products, combined with the credibility and reputation of their doctors, makes this relationship a tremendous benefit to the organization."

"We're very proud that the Rockets have recognized Texas Eye Institute as a leader in comprehensive vision care, and we look forward to serving the team and their fans for years to come," stated Charles A. Johnson, MD. A member of the Institute's award-winning team of specialists, Dr. Johnson is a Board Certified ophthalmologist, and he is considere
'/>"/>

SOURCE Texas Eye Institute
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
2. Texas Largest Physician Carrier Announces 5th Successive Rate Cut on Anniversary of Lawsuit Reform
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. South Texas Doctors Report More Severe Cases of Community Staph Super Bug Hospitalizing Children
5. Texas Aviation Services: Over 20 Years of Creating Flying Emergency Rooms for Airborne EMS Customers in US and Latin America
6. Dermatologists identify North Texas leishmaniasis outbreak
7. Precedent Launches Revolutionary Individual Health Insurance Plans in Texas
8. Health Care Service Corporation Provides Personal Clinical Summaries to Members of its Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas
9. Sesame Street Exhibition Makes Texas Premier at The Health Museum
10. The Law Offices of John David Hart: Texas Man Sues Medtronic in Body-Snatching Case
11. Viant Acquires Texas True Choice

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...aliforniaMakesLittleProgresstoImproveOverallOutcom...re-USNewswire/-- Today,LungCancerAlliance-Califor...er .The2009ReportCardisanassessmentofprogressbeing....LCA-CAisachapterofLungCancerAlliance(LCA),theonly...upportandadvocacyforpeoplelivingwithoratriskforlun...
(Date:11/25/2009)...ES (Nov. 25, 2009) Melvin R. Kaplan, MD, FACP, a ...research institute that became Los Angeles Biomedi...er (LA BioMed), will be honored by the American Co...he care of patients. , At its April 22, 2010 mee...s will present Dr. Kaplan with the Ralph O. Claypo...
(Date:11/25/2009)...n fruit fly study may lead to new drugs for people... (HealthDay News) -- Sphingadienes, natural lipid ...ent in treatments for colon cancer, California res...inary, but the study authors pointed out that they...ction against colon cancer. , In the study, Dr....
(Date:11/25/2009)... Citing support for recent enforceme...s, the National Association of Chain Drug Stores (...inistration (FDA). The letter expresses the Assoc... both domestic and foreign, that are engaged in a ...ing and dispensing of prescription medications. ,...
(Date:11/25/2009)...HINGTON,Nov.25/PRNewswire-USNewswire/--/EINNews/EI...sssyndication,introducesitsnewesthealth-relatedpub...wsToday( http://h1n1.einnews.com ). ,, H1N1News...micfromgovernments,newsoutletsandresearchcentersth...latestnewsontheglobaloutbreakwithreportsfromeverys...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2Health News:1 of LA BioMed's founders to be honored 2Health News:Natural Soy Component May Help Treat Colon Cancer 2Health News:NACDS Supports FDA Enforcement Against Rogue Internet Pharmacy Websites 2Health News:H1N1 News Today Examines the Swine Flu Virus From a Global Perspective; Read the Latest H1N1 Virus Vaccine & Prevention News From EIN News 2
...razil, Nov. 5 One of,Brazil,s leading distributor...ra de Produtos Farmaceuticos S.A. ("Profarma" or t...its results for the third quarter of,2007 (3Q07). ...prepared on consolidated bases in accordance with,...
....J., Nov 5. Collagen Matrix, Inc.,announces that ...ss(TM),Synthetic Mineral bone graft material inten...g bone repair. SynOss Synthetic Mineral is an ost...Oss, has a carbonate apatite,structure which is co...
...J., Nov. 5 Hooper Holmes,Inc. (AMEX: HH ) today ...nt,and CEO of Nabi Biopharmaceuticals Inc. (Nasdaq...oard of Directors. Dr. Hudson was previously,a mem...d to welcome him back to our,Board," said Benjamin...
...5 The following is a,statement from Men,s Health ... U.S. presidential candidates,are finally discussi...ited,States but abroad in the United Kingdom as we...ed to point out both,the U.S. and U.K. current pol...
... Nov. 5 Schering-Plough,Corporation (NYSE: SGP )...trict of Massachusetts has found no liability for ...n a class action lawsuit,involving several pharmac...led that Warrick,s,AWPs had no effect on Medicare ...
...v. 5 Law Offices of Howard G. Smith,announces a N...aintiff in,the securities class action lawsuit fil...mon stock of Care Investment Trust Inc. ("Care Inv...older lawsuit is pending in the United States Dist...
Other Medicine News:Health News:Profarma's Gross Revenues Reached R$ 698.2 Million in the 3rd Quarter 2007, a 31.9% Growth Over the Same Period Last Year and Net Income Rose by 94.9%, Respectively 2Health News:Collagen Matrix, Inc. Receives FDA 510(k) Clearance for SynOss(TM) Synthetic Mineral Bone Graft Material 2Health News:Hooper Holmes Appoints Leslie Hudson, PhD, to Board of Directors 2Health News:Hooper Holmes Appoints Leslie Hudson, PhD, to Board of Directors 3Health News:Statement From Men's Health Network: U.S. Presidential Candidates Overlook Real Problem in U.K. & U.S. Health Policies Towards Men 2Health News:Schering-Plough Reports U.S. District Court for District of Massachusetts Finds No Liability for Subsidiary in AWP Case 2Health News:Law Offices of Howard G. Smith Announces 14 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Care Investment Trust Inc. 2
(Date:11/24/2009)..., IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/-...yinvasivetreatmentsforaorticdisorders,announcedtod...eedingsin,thepatentinfringementlawsuitbroughtagain...UnitedStatesDistrictCourtinIndianapolis,Indiana. ,...twhiletheUnitedStatesPatentandTrademarkOffice(USPT...
(Date:11/24/2009)..., FREMONT,Calif.,Nov.24/PRNewswire-FirstCall/...theCompanyfileditsPlanofReorganizationandDisclosur...sBankruptcyCourtfortheDistrictofDelaware.Ahearingt...lyscheduledforDecember8,2009,withthehearingontheco..., ThePlancallsfortheCompanytopayallclaimsinfull.Th...
(Date:11/24/2009)..., WOODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewsw...U.S.FoodandDrugAdministration(FDA)hasacceptedforre...Aricept®(donepezilHClextendedrelease)tabletsf...(AD).Thisnewhigherdoseformulationcontains23mgofdon...adeliverysystemthatallowsforgradualreleaseofthedru...
Breaking Medicine Technology:Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Blood flow metabolism mismatch predicts pancreatic tumor aggressiveness 9697 1Blood flow metabolism mismatch predicts pancreatic tumor aggressiveness 9697 2Schwarzeneggers Budget Cuts Force Closure of California AIDS Clearinghouse 55311 1Schwarzeneggers Budget Cuts Force Closure of California AIDS Clearinghouse 55311 2Minorities have poorer results higher rates of inappropriate surgery to prevent stroke 55308 1Minorities have poorer results higher rates of inappropriate surgery to prevent stroke 55308 2
...ll/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ; TSX: ...n,endocrine therapy and oncology, today reported t...ruitment for its Phase 2 trial in ovarian cancer,w...one (LHRH) agonist,linked to doxorubicin. The deci...ent was taken following recent first stage data re...
...gual lozenge) developed to be the first sleep aid...hen patients awaken and have difficulty re...ranscept Pharmaceuticals,Inc., a privately-held sp...at it has submitted a New Drug Application (NDA) t...its lead product candidate, Intermezzo(R),(zolpide...
Other Medicine Technology:AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 3Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 4Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 6
...with the safety and comfort of the practitioner in...F-6) leaded glass, the industry standard for radia... as set for optical clarity, visible light transmi...ewear is protecting your eyes, it also helps you l...
...with the safety and comfort of the practitioner in...F-6) leaded glass, the industry standard for radia... as set for optical clarity, visible light transmi...ewear is protecting your eyes, it also helps you l...
Radiation Protection Goggles
Ultralight Jarrod Goggles
Medicine Products: